BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37039367)

  • 1. Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
    Dougherty EJ; Chen LY; Awad KS; Ferreyra GA; Demirkale CY; Keshavarz A; Gairhe S; Johnston KA; Hicks ME; Sandler AB; Curran CS; Krack JM; Ding Y; Suffredini AF; Solomon MA; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L783-L798. PubMed ID: 37039367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
    Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
    Gairhe S; Awad KS; Dougherty EJ; Ferreyra GA; Wang S; Yu ZX; Takeda K; Demirkale CY; Torabi-Parizi P; Austin ED; Elinoff JM; Danner RL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
    Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
    Wen B; Peng R; Kong P; Li Z; Liu Y; Ouyang W; Xie Y; Hu X; Wang Q; Pan X
    Am J Respir Cell Mol Biol; 2022 Dec; 67(6):666-679. PubMed ID: 36169661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells.
    Cheng SL; Shao JS; Behrmann A; Krchma K; Towler DA
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1679-89. PubMed ID: 23685555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
    Le Vely B; Phan C; Berrebeh N; Thuillet R; Ottaviani M; Chelgham MK; Chaumais MC; Amazit L; Humbert M; Huertas A; Guignabert C; Tu L
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):215-226. PubMed ID: 35550008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
    Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
    Sun X; Sun Y; Jiang P; Qi G; Chen X
    Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.
    Sahoo S; Li Y; de Jesus D; Sembrat J; Rojas MM; Goncharova E; Cifuentes-Pagano E; Straub AC; Pagano PJ
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H542-H557. PubMed ID: 34296965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of DLL4/NOTCH1 Causes Dysregulated PPARγ/AKT Signaling in Pulmonary Arterial Hypertension.
    Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38903104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1.
    Aranguren XL; Beerens M; Coppiello G; Wiese C; Vandersmissen I; Lo Nigro A; Verfaillie CM; Gessler M; Luttun A
    J Cell Sci; 2013 Mar; 126(Pt 5):1164-75. PubMed ID: 23345397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
    Wang Q; Tian J; Li X; Liu X; Zheng T; Zhao Y; Li X; Zhong H; Liu D; Zhang W; Zhang M; Li M; Zhang M
    Hypertension; 2022 May; 79(5):960-973. PubMed ID: 35249365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.
    Ghouleh IA; Sahoo S; Meijles DN; Amaral JH; de Jesus DS; Sembrat J; Rojas M; Goncharov DA; Goncharova EA; Pagano PJ
    Clin Sci (Lond); 2017 Aug; 131(15):2019-2035. PubMed ID: 28522681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression.
    Sissaoui S; Yu J; Yan A; Li R; Yukselen O; Kucukural A; Zhu LJ; Lawson ND
    Circ Res; 2020 Mar; 126(7):875-888. PubMed ID: 32065070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Walters R; Vasilaki E; Aman J; Chen CN; Wu Y; Liang OD; Ashek A; Dubois O; Zhao L; Sabrin F; Cebola I; Ferrer J; Morrell NW; Klinger JR; Wilkins MR; Zhao L; Rhodes CJ
    Circulation; 2023 May; 147(21):1606-1621. PubMed ID: 37066790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.